SPL 0.00% 9.7¢ starpharma holdings limited

Ann: SPL7013 COVID-19 nasal spray virucidal against SARS-CoV-2, page-130

  1. 15,434 Posts.
    lightbulb Created with Sketch. 5527
    Perhaps time for Starpharma to actually do something with DEP Remdesivir and Gilead instead of just 'chatting'

    https://www.medpagetoday.com/infectiousdisease/covid19/90008

    NIH Guidelines Shrink Scope of Remdesivir Use in COVID-19

    — Only dexamethasone now listed for sickest patients

    Updated National Institutes of Health guidelines narrowed the scope of recommended use for remdesivir (Veklury) in hospitalized COVID-19 patients, and the quality of evidence backing the drug's use also took a hit.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.7¢
Change
0.000(0.00%)
Mkt cap ! $40.00M
Open High Low Value Volume
9.8¢ 10.5¢ 9.6¢ $210.8K 2.098M

Buyers (Bids)

No. Vol. Price($)
1 30408 9.5¢
 

Sellers (Offers)

Price($) Vol. No.
9.7¢ 3523 2
View Market Depth
Last trade - 16.10pm 09/07/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.